IP Library Granted Patent US 7,700,351
Granted Patent B2
US 7,700,351 · App. 12/255,481 · Granted Apr 20, 2010

Methods and compositions for tissue regeneration

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,700,351
App. No.
12/255,481
Granted
Apr 20, 2010
Kind
B2
Abstract

Disclosed is a kit comprising a first component comprising fibrinogen, aprotinin, and a buffered solution, and a second component comprising, fibroblasts, keratinocytes, thrombin, glycerol, human serum albumin, and a buffered solution, wherein the first and second components are comprised in separate sterile containers.

Claims (23)

1. A kit comprising a container comprising:

(a) a first component comprising:

(i) fibrinogen;

(ii) aprotinin; and

(iii) a buffered solution,

wherein the first component is comprised in a first sterile vial; and

(b) a second component comprising:

(i) fibroblasts;

(ii) keratinocytes;

(iii) thrombin;

(iv) glycerol;

(v) human serum albumin; and

(vi) a buffered solution,

wherein the second component is comprised in a second sterile vial.

2. The kit of claim 1 , wherein the buffered solution in the first component is HBSS without Ca ++ and Mg ++ and the buffered solution in the second component is HBSS with Ca ++ and Mg ++ .

3. The kit of claim 2 , wherein the fibroblasts and keratinocytes are mitotically inactive.

4. The kit of claim 3 , wherein the first and second components are cryopreserved.

5. The kit of claim 4 , wherein the ratio of keratinocytes to fibroblasts is 1:9.

6. The kit of claim 5 , wherein the container further comprises a first and a second removable lid, wherein the first removable lid is affixed to the first sterile vial and the second removable lid is affixed to the second sterile vial.

7. The kit of claim 6 , wherein the kit further comprises spray pumps capable of replacing the removable lids.

8. The kit of claim 6 , wherein the container further comprises a first and a second pouch, wherein the first sterile vial is comprised in the first pouch and the second sterile vial is comprised in the second pouch.

9. The kit of claim 8 , wherein the first and second pouch is fabricated of a material capable of withstanding temperatures ranging from −80° C. to −160° C.

10. The kit of claim 9 , wherein the container is an outer pouch or case.

Assignments (6)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 30, 2015
From: ROLLAND, ERIC; HUNZIKER, THOMAS; CHEVALLAY, BEATRICE; RINSCH, CHRISTOPHER
To: ISOTIS SA
Reel/Frame 036219/0826 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 30, 2015
From: ISOTIS SA
To: EPISOURCE SA
Reel/Frame 036220/0155 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 30, 2015
From: EPISOURCE SA
To: DFB PHARMACEUTICALS, INC.
Reel/Frame 036220/0553 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 14, 2013
From: HEALTHPOINT INTERNATIONAL, LLC
To: SMITH & NEPHEW, INC.
Reel/Frame 029994/0633 →
CHANGE OF NAME Recorded Dec 17, 2012
From: DFB TECHNOLOGY HOLDINGS, LLC; HEALTHPOINT HOLDINGS, LLC
To: HEALTHPOINT INTERNATIONAL, LLC
Reel/Frame 029481/0540 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 14, 2010
From: DFB PHARMACEUTICALS, INC.
To: DFB TECHNOLOGY HOLDINGS, LLC
Reel/Frame 023788/0443 →